Active Headache & Migraine Studies

We are constantly seeking participants for a number of studies. Please apply to any studies for which you may qualify, or call us at (417) 883-7889 for more information!

If You Suffer from Migraines, Clinvest Is Here to Help

The piercing sensation from a headache or migraine can be debilitating. Our goal is to research and collect data on new medications that may be life-changing to this painful condition. We conduct a variety of headache and migraine studies with specific study topics ranging from chronic migraine prevention to post-traumatic headaches.

Clinvest knows how challenging and frustrating head pain can be. We have a strong commitment to further treatment and research in migraine studies. We partner with pharmaceutical companies in an effort to discover solutions for such debilitating conditions and look forward to the new horizons in health and well-being.

    Migraine Research Study

    AMGEN-2018060

    This is a trial to assess the effect of an investigational medication on disability and work productivity in employed subjects with episodic migraine who have previously failed 1 or more migraine preventive treatments. The study has 9 visits over approximately 31 weeks. Compensation for time and travel is up to $450.

    Duration: over approximately 31 weeks


    Number: 9 visits

    Migraine Device Study

    TCH-006

    This study is a chronic migraine study for ages 18-75 using a neuromodulator device on your upper arm. This device will sync via Bluetooth to a smartphone, which will control the device, as well as the location of headache diary. A total of up to 4 visits spanning no longer than 4 months with a 1-month baseline period and up to 3-months open-label period. Compensation may be provided for time and travel.

    Duration: 4 Months


    Number: 4

    Migraine Research Study

    STS101-002

    Clinvest is seeking volunteers with migraine. This study is evaluating the safety and effectiveness of STS101, a dihydroergotamine (DHE) dry powder formulation in a single-use nasal device that is being developed for the treatment of migraine. Qualified volunteers will treat one migraine attack and be randomly assigned to receive a device containing a single dose of study medication STS101 in one of two different doses or a matching placebo. The total duration of the study will be last up to approximately 12 weeks. Your first appointment would last approximately 2 hours with follow-up visits lasting around 1 hour. Study medication would be provided, as well as all study-related procedures, at no cost to you (including basic study-related physical exams, bloodwork, ECG’s, and urine drug/pregnancy tests). Compensation will be provided for your time and travel.

    Duration: 12 Weeks


    Number: 2+

Want to find out when new studies are available?

Fill out the form!